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The prevalence and prognostic implications of ventricular conduction disturbances in aortic
stenosis (AS) have not been extensively evaluated. The present retrospective study inves-
tigated the prevalence and prognostic implications of ventricular conduction abnormalities
(including the QRS morphology and duration) in AS. A total of 1,245 patients (mean age
66 ± 14 years, 62.8% men) with varying AS severity (aortic sclerosis 33.9%, mild AS 11.5%,
moderate AS 29.9%, and severe AS 24.7%) were evaluated. Demographic, clinical vari-
ables, and presence of ventricular conduction abnormalities on the electrocardiogram (based
on QRS morphology and duration) were related to occurrence of all-cause mortality, cor-
recting for occurrence of aortic valve replacement. The prevalence of ventricular conduction
disorders increased in parallel with AS severity, which was particularly significant for left
bundle branch block (4.3% in aortic sclerosis, 2.1% in mild AS, 4.6% in moderate AS, and
8.1% in severe AS; p = 0.042). The QRS duration showed a slight prolongation with in-
creasing AS severity (102 ± 21 ms in aortic valve sclerosis, 99 ± 18 ms in mild AS, 104 ± 22 ms
in moderate AS, and 105 ± 22 ms in severe AS; p = 0.044). During a mean follow-up of 8.1 ± 4.8
years, 40.9% of patients died. Right bundle branch block morphology (hazard ratio 1.59,
95% confidence interval 1.18 to 2.13, p = 0.002) and increase of QRS duration (hazard ratio
1.06, 95% confidence interval 1.02 to 1.11; p = 0.006) were independently associated with
all-cause mortality. In conclusion, ventricular conduction disorders became more preva-
lent with increasing severity of AS and have an impact on survival. © 2017 The Author(s).
Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/). (Am J Cardiol 2017;120:2226–2232)
Aortic valve stenosis (AS), one of the most common val-
vular diseases in developed countries, is a progressive process
of valve calcification and inflammation, which can affect the
conduction system directly through calcification and indi-
rectly through increased pressure afterload on the left ventricle
(LV).1 In patients with severe AS, ventricular conduction dis-
orders (left [LBBB] and right [RBBB] bundle branch block
or nonspecific intraventricular conduction delay [IVCD]) are
reported to be more prevalent than in the general population.2
However, the factors influencing the increased prevalence of
ventricular conduction disorders (QRS morphology and du-
ration) are poorly understood and have not been evaluated
in a large cohort of patients with varying grades of AS. Fur-
thermore, the prognostic value of ventricular conduction
disturbances have been studied only in specific subpopulations
of patients with AS.3,4 Therefore, the present study aimed at
investigating the prevalence of ventricular conduction disor-
ders in a large registry of patients with AS and the prognostic
relevance of QRS morphology and duration in this population.
Methods
Patients with native AS were identified from the depart-
mental echocardiographic database at the Leiden University
Medical Center (Leiden, The Netherlands) from December
1993 to August 2015.5 Patients with prosthetic aortic valves,
subvalvular or supravalvular AS, dynamic subaortic obstruc-
tion, coexisting (moderate or severe) aortic regurgitation,
coexisting (moderate or severe) mitral regurgitation, and active
endocarditis were excluded. In addition, patients with pace-
maker rhythm were excluded.
Clinical history, physical examination, transthoracic
echocardiography, and resting 12-lead electrocardiogram
(ECG) were evaluated at time of first diagnosis of AS. Base-
line clinical variables included cardiovascular risk factors, total
cholesterol levels, hemoglobin level, and glomerular filtra-
tion rate calculated by the Modification of Diet in Renal
Disease formula.6 All patients were followed up for the oc-
currence of all-cause mortality. The association between QRS
duration and morphology across the AS grade groups and all-
cause mortality at follow-up was investigated in this analysis.
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Patient data were collected in the departmental Cardiol-
ogy Information System (EPD-Vision; Leiden University
Medical Centre, Leiden, the Netherlands) and analyzed ret-
rospectively. This retrospective analysis of clinically acquired
data was approved by the institutional review board of the
Leiden University Medical Center, and the need for patient
written informed consent was waived.
Standard resting 12-lead ECGs performed within 12 months
before or after the date of the index echocardiogram were in-
cluded in the analysis and retrospectively assessed. Calibration
of the ECG was set at 0.1 mV/mm, and the paper speed was
25 mm/s. Sinus rhythm and atrial fibrillation were defined as
recommended by current guidelines.7 The QRS morphol-
ogy was analyzed, and patients were divided based on the
presence of LBBB, RBBB, and IVCD.8 In addition, QRS du-
ration was measured in milliseconds in the ECG lead with
the greatest QRS width. The study population was divided
into 2 groups according to the presence of a QRS duration
≥130 ms or <130 ms, as previously described.4
Transthoracic echocardiography was performed in all pa-
tients at rest using commercially available ultrasound systems
(Vivid 7 and E9 systems; GE-Vingmed, Horten, Norway).
All images were digitally stored on hard disks for offline
analysis (EchoPAC version 113.0.3; GE Vingmed). Two-
dimensional, color, pulsed, and continuous-wave Doppler data
were acquired according to standard techniques. LV end-
diastolic and end-systolic volumes were calculated using the
Simpson’s biplane method of discs and indexed to body surface
area.9 The LV ejection fraction was calculated and ex-
pressed as a percentage. The LV mass was calculated from
the two-dimensional LV linear measurements obtained on the
parasternal LV long-axis view as recommended,9 and indexed
to body surface area. From the apical LV long-axis or
5-chamber views, continuous-wave Doppler spectral record-
ings through the aortic valve were obtained, and the mean
pressure gradient was estimated with the modified Ber-
noulli equation. The aortic valve area (AVA) was calculated
with the continuity equation. The severity of AS was deter-
mined by the peak jet velocity, mean gradient, and calculated
AVA, and classified into different categories (sclerosis, mild,
moderate, and severe), as currently recommended.10
Patients were followed up for the occurrence of all-
cause mortality. Survival data were complete for all subjects,
and collected from the departmental cardiology information
system or the Social Security Death Index.
All continuous variables were tested for Gaussian distri-
bution and were presented as mean ± standard deviation unless
otherwise stated. All categorical variables were presented as
frequencies and percentages. The cumulative event rates for
the clinical end point of all-cause mortality were estimated
with the Kaplan-Meier survival curves, and log-rank testing
was used to compare the groups (QRS morphology [narrow
QRS, LBBB, RBBB, IVCD] and QRS duration ≥130 ms vs
<130 ms). Multivariable Cox proportional hazards regres-
sion analysis was performed to investigate the independent
association between QRS morphology and duration with the
clinical end point of all-cause mortality. Clinical and
echocardiographic parameters known to influence mortality
in patients with AS were chosen a priori based on published
studies and incorporated as covariates in the model.4,11 In ad-
dition, subsequent aortic valve replacement (AVR) during
follow-up was treated as a time-dependent covariate in the
model. Hazard ratios (HR) and 95% confidence intervals (CI)
were calculated. A 2-tailed p value of <0.05 was considered
significant. All statistical analyses were performed using SPSS
Statistics 23 (SPSS Inc; Armonk, NY: IBM Corp) and STATA
version 12 (STATA Corporation, College Station, TX).
Results
The final population comprised 1,245 patients with AS
(Figure 1). The mean age at first AS diagnosis was 66 ± 14
years, and 62.8% were men. The mean AVA, mean gradi-
ent, and peak jet velocity were 1.47 ± 0.68 cm2, 22.4 ± 17.0 mm
Hg, and 2.8 ± 1.0 m/s, respectively. A total of 422 (33.9%)
patients had aortic sclerosis, 143 (11.4%) had mild AS, 372
(29.9%) had moderate AS, and 308 (24.8%) had severe AS.
The majority of patients showed narrow QRS complex
(n = 942, 76%), whereas the prevalence of LBBB, RBBB, and
IVCD was 5%, 7%, and 12%, respectively. The number of
patients with QRS duration ≥130 ms was 154 (12.4%). Table 1
shows the different patient characteristics according to the dif-
ferent QRS morphologies.
Figure 2 summarizes the distribution of different QRS mor-
phologies and QRS duration across the various grades of AS.
The prevalence of ventricular conduction disorders in-
creased along the severity of AS, which was particularly
significant for LBBB morphology (4.3% in aortic valve scle-
rosis, 2.1% in mild AS, 4.6% in moderate AS, and 8.1% in
severe AS; p = 0.042). The QRS duration showed a slight pro-
longation with increasing severity of AS (102 ± 21 ms in aortic
valve sclerosis, 99 ± 18 ms in mild AS, 104 ± 22 ms in mod-
erate AS, and 105 ± 22 ms in severe AS; p = 0.044).
During a mean follow-up of 8.1 ± 4.8 years, 533 (42.8%)
patients underwent AVR (75 had transcatheter aortic valve
implantation), and 509 (40.9%) patients died. Figure 3 shows
that the cumulative event-free survival was significantly worse
in patients with RBBB morphology than in patients with
narrow QRS (HR 1.72, CI 1.28 to 2.30, p <0.001). There was
no difference in survival between patients with narrow QRS
versus patients with LBBB (HR 1.247, CI 0.832 to 1.870,
p = 0.286) and patients with IVCD (HR 1.23, CI 0.95 to 1.60,
p = 0.122). When analyzing the prognostic effect of QRS du-
ration, we found that patients with QRS duration ≥130 ms
showed significantly worse survival than did patients with QRS
duration <130 ms (HR 1.63, CI 1.28 to 2.07, p <0.001;
Figure 3).
To determine the independent prognostic value of differ-
ent QRS morphologies and QRS duration in all grades of AS,
a multivariable Cox proportional hazards model was con-
structed with significant univariate determinants entered as
covariates (Table 2). Age, AVA, LV ejection fraction, and sub-
sequent AVR were significantly associated with all-cause
mortality in the univariate analysis. Two different models were
then constructed to evaluate the additional prognostic sig-
nificance of QRS morphology and QRS duration on top of
the clinical baseline model (Table 3). Both QRS morphol-
ogy and QRS duration were significantly associated with all-
cause mortality. The presence of RBBB was significantly
associated with worse prognosis than narrow QRS, whereas
LBBB and IVCD morphologies were not independently as-
sociated with increased all-cause mortality. In addition, each
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10-ms increase in QRS duration was independently associ-
ated with 6% increase in the risk of all-cause mortality.
Figure 4 shows that addition of QRS morphology and
QRS duration to the baseline model resulted in an equiva-
lent and significant increase in the chi-square (baseline
model chi-square = 54.7; baseline + QRS morphology model
chi-square = 65.2, p = 0.027; baseline + QRS duration model
chi-square = 63.7, p = 0.007), indicating an incremental value
of QRS morphology (RBBB) and QRS duration in risk strati-
fication of patients with AS.
Discussion
The prevalence of ventricular conduction disorders, par-
ticularly LBBB QRS morphology, increased along with the
severity of AS. Both QRS duration and morphology were in-
dependently associated with all-cause mortality in patients
with AS. Specifically, patients with RBBB morphology showed
worse prognosis than did patients without RBBB. Whether
these patients need careful follow-up and perhaps earlier valve
replacement needs to be elucidated in prospective random-
ized studies.
An increased prevalence of ventricular conduction disor-
ders in severe AS has been demonstrated in several studies.12–15
In a large meta-analysis including 5,258 patients with severe
AS undergoing transcatheter aortic valve implantation, a high
percentage of preprocedural ventricular conduction disor-
ders (LBBB 13%, RBBB 11%) was reported.2 In the present
study (involving an unselected cohort of patients with AS)
we confirm and extend this relation by showing a significant
increase of ventricular conduction disorders (LBBB, RBBB,
and IVCD) and a significant increase in mean QRS dura-
tion with increasing severity of AS. More importantly, this
progressive increase in conduction disorders is mainly de-
termined by a significant increase in LBBB morphology (4-
fold more frequent in severe versus mild AS, p = 0.042).
Several anatomic and hemodynamic mechanisms under-
lying the occurrence of ventricular conduction disorders in
AS have been described. The close proximity of the aorta-
mitral fibrous continuity to the His bundle and the origin of
the left bundle branch can be affected by progressive calci-
fication of the aortic valve.16 In addition, the increased pressure
afterload imposed by the stenotic valve leads to compensa-
tory LV hypertrophy, increased wall stress, relative ischemia,
and subsequent deterioration of LV function and develop-
ment of fibrosis, which can further lead to slow ventricular
conduction.1 The association between longer QRS duration
and myocardial fibrosis has been demonstrated in a previ-
ous histologic study, including mainly individuals with
ischemic heart disease.17
To date, only 2 studies have focused on the prognostic im-
plications of QRS duration and morphology in patients with
AS.3,4 A sub-study of the Simvastatin and Ezetimibe in Aortic
Stenosis study,3 including 1,542 asymptomatic patients with
mild to moderate AS, demonstrated that prolonged QRS du-
ration and LBBB or combined RBBB and left anterior
fascicular block QRS morphologies were associated with poor
prognosis. Noteworthy, in the Simvastatin and Ezetimibe in
Aortic Stenosis study, the number of patients with QRS du-
ration ≥120 ms was relatively low (6.5% of the total
Figure 1. Flowchart of inclusion of patients with aortic stenosis. AS = aortic stenosis; ECG = electrocardiogram; IVCD = nonspecific ventricular conduction
delay; LBBB = left bundle branch block; RBBB = right bundle branch block.
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population), and the number of events at follow-up was also
low, precluding the assessment of independent associates of
outcome. In addition, in 88 patients with low flow, low gra-
dient severe AS, wide QRS complex (≥130 ms) was
significantly associated with all-cause mortality.4 The current
study is the first to demonstrate that QRS duration and mor-
phology are significantly associated with all-cause mortality
in a large group of patients with AS with a broad spectrum
of AS severity. The risk of all-cause mortality increased pro-
gressively with longer QRS duration, and this association was
modulated by QRS morphology.
The present retrospective evaluation has some limita-
tions. Because of the retrospective design of the present study,
including patients referred to a tertiary center, there may be
a potential selection bias. The primary end point was all-
cause mortality because these data are uniformly available,
whereas cardiovascular death or other specific causes of death
were not systematically available. Furthermore, the pres-
ence of atrioventricular block or concomitant fascicular block
was not collected. Although the ECG and echocardiographic
data were restricted for inclusion if they coincided within a
12-month time frame, we cannot exclude any confounding
Table 1




block (n = 63)
Right bundle branch
block (n = 92)
Intraventricular conduction
disorder (n = 148)
P-value*
Age (years) 66 ± 14 72 ± 11 70 ± 13 67 ± 12 <0.001
Men 59.4% 58.7% 78.3% 76.4% <0.001
Body mass index (kg/m2) 25.4 ± 5.9 24.5 ± 7.1 25.2 ± 6.3 25.9 ± 6.4 0.333
Hypertension 51.4% 53.7% 61.9% 56.8% 0.335
Diabetes mellitus 19.4% 21.4% 15.9% 21.9% 0.806
Previous myocardial infarction 15.7% 25.6% 30.2% 21.9% 0.009
New York Heart Association
functional class
0.718
III/IV 19.5% 27.5% 17.5% 14.5%
Chronic obstructive pulmonary
disease
10.8% 7.1% 12.7% 10.4% 0.842
Previous malignancy 14.2% 7.1% 9.5% 10.4% 0.345
Symptoms 67.3% 68.3% 74.6% 72.6% 0.517
Laboratory
Haemoglobin (g/dL) 13.3 ± 1.9 13.3 ± 1.9 13.5 ± 2.1 13.8 ± 1.8 0.184
Estimated glomerular filtration
rate (mL/min/1.73 m2)
72.2 ± 25.9 65.3 ± 27.3 70.8 ± 23.7 65.3 ± 23.1 0.054
Total cholesterol (mg/dL) 197.5 ± 50.8 209.7 ± 79.8 202.2 ± 46.9 191.6 ± 39.9 0.573
Echocardiography
Heart rate (beats/min) 73 ± 14 75 ± 14 71 ± 15 71 ± 15 0.175
Peak aortic valve jet velocity
(m/s)
2.8 ± 1.0 2.9 ± 1.0 2.9 ± 1.0 2.9 ± 1.0 0.567
Mean aortic valve gradient
(mmHg)
23.1 ± 14.9 23.1 ± 14.9 22.6 ± 16.8 23.7 ± 16.8 0.734
Aortic valve area (cm2) 1.50 ± 0.69 1.18 ± 0.49 1.45 ± 0.68 1.41 ± 0.66 0.005
Bicuspid aortic valve 10.7% 5.4% 6.3% 12.9% 0.344
Left ventricular mass index
(g/m2)
113.7 ± 31.9 141.6 ± 43.0 122.5 ± 37.3 137.6 ± 37.8 <0.001
Left ventricular end-diastolic
volume index (mL/m2)
50.1 ± 16.8 69.9 ± 26.2 59.4 ± 29.2 63.4 ± 22.2 <0.001
Left ventricular end-systolic
volume index (mL/m2)
21.6 ± 11.7 41.2 ± 23.3 29.1 ± 25.9 31.3 ± 7.7 <0.001
Left ventricular ejection
fraction (%)
58.2 ± 9.7 43.5 ± 14.4 55.3 ± 11.8 53.0 ± 12.2 <0.001
Electrocardiography
QRS duration (ms) 93 ± 8 147 ± 21 144 ± 17 120 ± 11 <0.001
Atrial fibrillation 6.5% 17.5% 8.7% 8.8% 0.012
Medication
Antiplatelet/anticoagulant 42.3% 68.3% 54.0% 46.9% 0.004
Beta-blockers 39.8% 46.3% 42.9% 38.5% 0.807
Calcium channel blockers 21.7% 26.8% 25.4% 31.3% 0.186
Renin-angiotensin-aldosterone
inhibitors
41.8% 63.4% 42.9% 50.0% 0.029
Statins 39.5% 63.4% 50.8% 34.4% 0.004
Diuretics 27.9% 56.1% 30.2% 39.6% <0.001
Values are mean ± SD or percentages.
* p Value by 1-way ANOVA, and chi-square test for continuous and categorical variables, respectively.
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Figure 2. Distribution of (A) QRS morphology and (B) QRS duration in various grades of aortic stenosis. With increasing severity of aortic stenosis, there
was a significant increase in prevalence of QRS conduction disorders (narrow vs IVCD, RBBB, and LBBB) and a significant increase in mean QRS dura-
tion. AS = aortic stenosis; IVCD = interventricular conduction delay; LBBB = left bundle branch block; RBBB = right bundle branch block.
Figure 3. Kaplan-Meier survival curves in patients divided according to QRS morphology (A) and QRS duration (B).IVCD = nonspecific ventricular con-
duction delay; LBBB = left bundle branch block; RBBB = right bundle branch block.
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influence attributable to this timeframe. However, all pa-
tients were in stable conditions without AVR in this period.
In conclusion, the prevalence of ventricular conduction dis-
orders increased in parallel with increasing AS severity. Longer
QRS duration and RBBB morphology were independently
associated with all-cause mortality in AS.
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